UPDATE : Friday, January 17, 2020
상단여백
‘Roche's Xofluza to revolutionize influenza antivirals’ by Lee Han-soo 2019-12-17 16:30
‘Local medical device industry needs state support to grow’ by Kim Eun-young 2019-12-17 16:01
Novartis reaffirms efficacy of Tasigna in treating chronic myelogenous leukemia by Lee Han-soo 2019-12-17 14:48
Venture capital investment in biomedical sector to hit record this year by Jeong Sae-im 2019-12-17 14:20
CDK4/6+fulvestrant combo may get benefit in 1st half of 2020 by Kim Yun-mi 2019-12-17 11:59
라인
CJ Healthcare unites with Standigm to develop AI-based anticancer drugs by Lee Han-soo 2019-12-17 11:58
[News Focus] 'You, too, can use millions of patients’ data for research' by Park Gi-taek 2019-12-16 17:08
Celltrion secures 11 generic drugs to advance to US market by Lee Han-soo 2019-12-16 17:02
Dong-A, Meiji Seika to conduct P1 trial for Stelara biosimilar by Lee Han-soo 2019-12-16 17:01
Patient cries for stem cell therapy approval to stop heart necrosis by Choi Gwang-seok 2019-12-16 15:27
라인
Huons Lab, Pangen to codevelop human genetic recombinant hyaluronidase by Lee Han-soo 2019-12-16 15:23
'Biosurveillance essential as no leader want absence of information during health crisis' by Lee Han-soo 2019-12-16 15:23
Korea, China, Japan to cooperate on universal health coverage, infectious disease, aging by Kwak Sung-sun 2019-12-16 12:47
KDA tells patients not to stop taking metformin arbitrarily by Lee Han-soo 2019-12-16 10:56
GC, Add Pharma to co-develop synthetic drugs by Lee Han-soo 2019-12-13 16:25
라인
Helixmith to clarify why gene therapy study had data error by Jeong Sae-im 2019-12-13 15:13
Daewoong releases trial results for autoimmune disease treatment candidate by Lee Han-soo 2019-12-13 15:12
Medical kiosks installed at major subway stations to help foreigners by Lee Han-soo 2019-12-13 13:58
Regulator finds harmful substances in liquid e-cigarettes by Kim Yun-mi 2019-12-13 13:58
Curexo launches 1st locally developed spine surgery robot by Lee Han-soo 2019-12-13 13:39
여백
여백
여백
Back to Top